课题基金 / 基金详情

Genetic Analysis and Manipulation Core (GAEC)

Genetic Analysis and Manipulation Core (GAEC)
遗传分析和操作核心 (GAEC)
批准号:
10239466
负责人:
CLIFFORD J WOOLF
金额:
$29.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-22 至 2026-05-31
关键词:
AddressAdoptedAnimal ModelBioinformaticsBiologicalBiological AssayBiologyBostonCRISPR/Cas technologyCell modelCellsClinicalClustered Regularly Interspaced Short Palindromic RepeatsConsultConsultationsCore FacilityCorrelation StudiesCre driverCryopreservationDNADNA purificationDNA sequencingData AnalysesDevelopmentDevelopmental DisabilitiesDideoxy Chain Termination DNA SequencingDiseaseDisease modelExperimental DesignsFunctional disorderGene ExpressionGene Expression ProfilingGene TargetingGenerationsGenesGeneticGenetic ModelsGenomeGenotypeGoalsHumanIndividualIntellectual and Developmental Disabilities Research CentersIntellectual functioning disabilityKnock-in MouseKnock-outLinkMeasuresMethodologyModelingMolecularMouse Cell LineMusMutationMutation DetectionPatient RecruitmentsPediatric HospitalsPhenotypePhysiologyPlasmidsPoint MutationPostdoctoral FellowPre-Clinical ModelProteinsQuality ControlReporterResearch PersonnelResearch Project GrantsResourcesScientistServicesSpecimenStructureTechniquesTechnologyTestingTherapeuticTherapeutic InterventionTimeTissuesanimal model developmentbasebioinformatics toolclinical trial readinesscostcost effectivedevelopmental diseasedigitalexperimental studygene discoverygenetic analysisgenetic manipulationgenetic testinggenomic toolshuman modelinduced pluripotent stem cellmouse genomemouse modelnano-stringnervous system developmentneurodevelopmentnew technologynext generation sequencingnovelpatient orientedpotential biomarkersingle-cell RNA sequencingtooltranscriptomicsvariant detection

项目摘要

项目成果

CLIFFORD J WOOLF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT The Genetic Analysis and Editing Core (GAEC) provides cost-effective, state-of-the-art molecular tools and consulting/bioinformatic services to IDDRC investigators for 1). Sequencing DNA at all scales, 2). Development of gene editing strategies for cellular and animal models of human neurodevelopmental disease, and 3). Quantitative analyses of gene expression in normal and diseased cells and tissues. GAEC offers services through its Genetic Analysis Group (GAG) and the Gene Editing Group (GEG). The GAG offers Sanger sequencing to validate plasmid constructs, sequence PCR products and for all molecular experiments requiring DNA sequencing, and a full suite of assays and tools for genomic-level analysis, starting with high throughput DNA purification, quantification and quality control assays, analytical DNA testing including genotyping in low, medium and high throughput formats, Sanger and next generation sequencing (NGS), structural variant detection, and low, medium and high throughput gene expression studies including single cell transcriptomics. Bioinformatic support is also provided. The GEG enables the development of animal models of human IDDs utilizing the latest gene targeting approaches and specializes in gene editing of the mouse genome via CRISPR/Cas9 (Clustered regularly interspaced short palindromic repeat)/(CRISPR associated protein) which enables generation of novel gene-edited mouse lines with point mutations, insertions or deletions in a single step. A cryopreservation service is also offered as well as advice on editing strategies and genotyping. Consolidation of these overlapping analytic and editing technologies within a single core facility serving multiple investigators allows individual investigators access to specialized techniques and to use these to identify IDDRC related mutations, model these in mice and cell lines, and measure changes in gene expression in tissues or at a single cell level. The combination of two pre-existing cores into a single integrated core brings their overlapping activities into better alignment and offers a more comprehensive and complete service to IDDRC investigators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2: The cell types and states of painful neuromas
  • 批准号:
    10707429
  • 项目类别:
  • 资助金额:
    $45.14万
  • 财政年份:
    2022
  • 负责人:
    CLIFFORD J WOOLF
  • 依托单位:
Project 2: The cell types and states of painful neuromas
  • 批准号:
    10594337
  • 项目类别:
  • 资助金额:
    $35.23万
  • 财政年份:
    2022
  • 负责人:
    CLIFFORD J WOOLF
  • 依托单位:
Identification of susceptibility to chemotherapy induced peripheral neuropathy using patient stem cell derived sensory neurons
  • 批准号:
    9385404
  • 项目类别:
  • 资助金额:
    $8.85万
  • 财政年份:
    2017
  • 负责人:
    CLIFFORD J WOOLF
  • 依托单位:
Unravelling mechanisms and novel therapeutic targets for peripheral neuropathy and neuropathic pain
  • 批准号:
    10063580
  • 项目类别:
  • 资助金额:
    $132.75万
  • 财政年份:
    2017
  • 负责人:
    CLIFFORD J WOOLF
  • 依托单位:
海外基金